Kiora shareholders elect directors, approve say-on-pay and auditor at annual meeting

KIORA PHARMACEUTICALS INC

Carmine Stengone and Brian M. Strem elected as Class I directors for three-year term.
Non-binding advisory vote on named executive officer compensation approved (1,144,829 for, 82,389 against).
Ratification of Haskell & White LLP as independent auditor for FY2025 passed (1,567,427 for, 78,598 against).

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.